Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atorvastatin”

731 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 731 results

Post-approval studies (Phase 4)Study completedNCT00770796
What this trial is testing

Statins for Prevention of Contrast Induced Nephropathy

Who this might be right for
Contrast Induced Nephropathy
Ospedale Misericordia e Dolce 304
Not applicableStudy completedNCT00329069
What this trial is testing

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaMonocyte Function
University of Ulm 50
Large-scale testing (Phase 3)Study completedNCT00844402
What this trial is testing

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary CirrhosisHypercholesterolemia
Medical University of Graz 40
Large-scale testing (Phase 3)Study completedNCT00654537
What this trial is testing

STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

Who this might be right for
Hypercholesterolemia
AstraZeneca 5,625
Testing effectiveness (Phase 2)Looking for participantsNCT06485336
What this trial is testing

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

Who this might be right for
Chronic Migraine
St. Olavs Hospital 300
Very early researchLooking for participantsNCT06961630
What this trial is testing

Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

Who this might be right for
Myocardial Injury After Noncardiac Surgery
NYU Langone Health 50
Large-scale testing (Phase 3)Study completedNCT01073800
What this trial is testing

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill

Who this might be right for
Myocardial InfarctionStrokeRenal Failure
University of Alberta 100
Post-approval studies (Phase 4)Active Not RecruitingNCT04789057
What this trial is testing

Atorvastatin Effect on Reduction of COPD Exacerbations

Who this might be right for
CopdCOPD ExacerbationSmoking+2 more
Medical University of Bialystok 460
Not applicableStudy completedNCT00572312
What this trial is testing

Optimalization of Nephroprotection Using Atorvastatin (Sortis)

Who this might be right for
Chronic Kidney DiseaseProteinuria
Medical University of Gdansk
Testing effectiveness (Phase 2)Study completedNCT01732718
What this trial is testing

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Nephropathy
University of North Carolina, Chapel Hill 13
Testing effectiveness (Phase 2)Study completedNCT05561062
What this trial is testing

Atorvastatin in Patients With Ulcerative Colitis

Who this might be right for
Inflammatory Bowel Diseases
Tanta University 50
Testing effectiveness (Phase 2)Study completedNCT00864643
What this trial is testing

Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 172
Large-scale testing (Phase 3)Study completedNCT02114346
What this trial is testing

High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

Who this might be right for
Contrast-Induced Nephropathy
Isfahan University of Medical Sciences 250
Post-approval studies (Phase 4)Study completedNCT00120055
What this trial is testing

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

Who this might be right for
Myopathy
University of Oslo School of Pharmacy
Testing effectiveness (Phase 2)Active Not RecruitingNCT06157099
What this trial is testing

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma

Who this might be right for
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8Pathologic Stage IIA Cutaneous Melanoma AJCC v8Pathologic Stage IIB Cutaneous Melanoma AJCC v8
OHSU Knight Cancer Institute 150
Large-scale testing (Phase 3)Study completedNCT01820767
What this trial is testing

Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

Who this might be right for
Chronic Kidney Disease
Ricardo Mouzo Mirco 31
Large-scale testing (Phase 3)Study completedNCT00065806
What this trial is testing

Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)

Who this might be right for
Lupus Erythematosus, Systemic
Laura Schanberg 221
Post-approval studies (Phase 4)Study completedNCT01299181
What this trial is testing

A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Bronchiectasis
University of Edinburgh 60
Large-scale testing (Phase 3)Study completedNCT01278459
What this trial is testing

Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?

Who this might be right for
Pre-Eclampsia
University of Oxford 11
Large-scale testing (Phase 3)Study completedNCT00435045
What this trial is testing

Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 245
Next Page